×
About 459 results

ALLMedicine Primary Pulmonary Hypertension Center

Research & Reviews  199 results

Single Lung Transplant vs Double Lung Transplant: A Single-Center Experience With Parti...
https://doi.org/10.1016/j.transproceed.2020.03.046
Transplantation Proceedings; Antończyk R, Stącel T et. al.

May 31st, 2020 - Lung transplant remains the only viable treatment for certain patients with end-stage lung diseases. Such patients can become either single or double lung recipients. The 2 procedures are associated with specific risks and benefits. The aim of the...

Extracorporeal Membrane Oxygenation as a Postoperative Left Ventricle Conditioning Tool...
https://doi.org/10.1016/j.transproceed.2020.02.113
Transplantation Proceedings; Stącel T, Antończyk R et. al.

Apr 6th, 2020 - Primary pulmonary hypertension can lead to hypertrophy of the right ventricle and ultimately to its insufficiency. Lung transplantation remains the only viable treatment for patients with certain forms of this disease. Usage of extracorporeal memb...

Exceptional LAS Requests in Eurotransplant: Analysis of an 8-year Effort to Improve Lun...
https://doi.org/10.1016/j.healun.2020.01.475
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation; Vos R, Smits JM et. al.

Mar 29th, 2020 - Following introduction of the lung allocation score (LAS) in 2011, Eurotransplant member centers can apply for an exceptional LAS (eLAS) if the calculated LAS insufficiently reflects the perceived transplant benefit for a patient, specifically in ...

First Series of Combined Heart & Lung Transplantation from India.
https://doi.org/10.1016/j.healun.2020.01.505
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation; Rahulan V, Yadav P et. al.

Mar 29th, 2020 - This study analyses the data of patients undergoing Combined heart and lung transplant(CHLTx) with primary pulmonary hypertension(PPH),advanced lung diseases with right ventricular failure and uncorrected congenital heart diseases which are not un...

Endothelial Cell Dysfunction in Pulmonary Hypertension
https://clinicaltrials.gov/ct2/show/NCT00098072

Mar 16th, 2020 - Introduction: Primary pulmonary hypertension, now known as idiopathic pulmonary arterial hypertension (IPAH), a subgroup of pulmonary arterial hypertension (PAH), is a rare disorder characterized by severe morbidity and high mortality rates. There...

see more →

Clinicaltrials.gov  229 results

Single Lung Transplant vs Double Lung Transplant: A Single-Center Experience With Parti...
https://doi.org/10.1016/j.transproceed.2020.03.046
Transplantation Proceedings; Antończyk R, Stącel T et. al.

May 31st, 2020 - Lung transplant remains the only viable treatment for certain patients with end-stage lung diseases. Such patients can become either single or double lung recipients. The 2 procedures are associated with specific risks and benefits. The aim of the...

Extracorporeal Membrane Oxygenation as a Postoperative Left Ventricle Conditioning Tool...
https://doi.org/10.1016/j.transproceed.2020.02.113
Transplantation Proceedings; Stącel T, Antończyk R et. al.

Apr 6th, 2020 - Primary pulmonary hypertension can lead to hypertrophy of the right ventricle and ultimately to its insufficiency. Lung transplantation remains the only viable treatment for patients with certain forms of this disease. Usage of extracorporeal memb...

Exceptional LAS Requests in Eurotransplant: Analysis of an 8-year Effort to Improve Lun...
https://doi.org/10.1016/j.healun.2020.01.475
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation; Vos R, Smits JM et. al.

Mar 29th, 2020 - Following introduction of the lung allocation score (LAS) in 2011, Eurotransplant member centers can apply for an exceptional LAS (eLAS) if the calculated LAS insufficiently reflects the perceived transplant benefit for a patient, specifically in ...

First Series of Combined Heart & Lung Transplantation from India.
https://doi.org/10.1016/j.healun.2020.01.505
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation; Rahulan V, Yadav P et. al.

Mar 29th, 2020 - This study analyses the data of patients undergoing Combined heart and lung transplant(CHLTx) with primary pulmonary hypertension(PPH),advanced lung diseases with right ventricular failure and uncorrected congenital heart diseases which are not un...

Endothelial Cell Dysfunction in Pulmonary Hypertension
https://clinicaltrials.gov/ct2/show/NCT00098072

Mar 16th, 2020 - Introduction: Primary pulmonary hypertension, now known as idiopathic pulmonary arterial hypertension (IPAH), a subgroup of pulmonary arterial hypertension (PAH), is a rare disorder characterized by severe morbidity and high mortality rates. There...

see more →

News  29 results

Avenues for protecting against vasculopathy in systemic sclerosis
https://www.mdedge.com/dermatology/article/82448/lupus-connective-tissue-diseases/avenues-protecting-against-vasculopathy/page/0/1

May 19th, 2014 - Endothelin inhibitors Endothelin inhibitors also may play a role in vascular protection. Endothelin is secreted in scleroderma and is a potent vasoconstrictor.

Updating the Definition of PAH
https://www.medscape.com/viewarticle/522583

Feb 9th, 2006 - Question I am curious whether experts still distinguish between primary pulmonary hypertension and secondary pulmonary hypertension when it comes to treating a specific patient, or do they simply follow the NYHA/WHO functional classification (FC) ...

Bosentan to improve survival in primary pulmonary hypertension? More data to come, authors say
https://www.medscape.com/viewarticle/785640

Apr 23rd, 2003 - Thu, 24 Apr 2003 14:45:00 Chicago, IL - Bosentan (Tracleer®, Actelion), combined with rescue epoprostenol (Flolan®, Glaxo-SmithKline) if needed, may improve "expected" survival in patients with primary pulmonary hypertension (PPH), researchers say...

Epoprostenol improves survival in primary pulmonary hypertension
https://www.medscape.com/viewarticle/785993

Aug 25th, 2002 - Mon, 26 Aug 2002 21:49:00 Dallas, TX - As new agents are developed for the treatment of primary pulmonary hypertension (PPH), long-term data are now becoming available on the first drug approved for this indication, intravenous epoprostenol (Flola...

Misdiagnosis of familial primary pulmonary hypertension could hinder disease management
https://www.medscape.com/viewarticle/786522

Jul 31st, 2001 - Wed, 01 Aug 2001 21:00:00 Boston, MA Many patients with apparent sporadic primary pulmonary hypertension (PPH) have actually been misdiagnosed and have a familial form of the disease, according to a report in the August 2, 2001 issue of the New En...

see more →

Patient Education  2 results see all →